Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus.

Congenital nephrogenic diabetes insipidus.

Congenital nephrogenic diabetes insipidus with end-stage renal disease.

Congenital nephrogenic diabetes insipidus in a baby girl.

Congenital nephrogenic diabetes insipidus with a novel mutation in the aquaporin 2 gene.

Pemetrexed-Induced Nephrogenic Diabetes Insipidus.

Novel autosomal recessive gene mutations in aquaporin-2 in two Chinese congenital nephrogenic diabetes insipidus pedigrees.

Aquaporin-2: new mutations responsible for autosomal-recessive nephrogenic diabetes insipidus-update and epidemiology.

Drug-induced states of nephrogenic diabetes insipidus.

Nephrogenic diabetes insipidus in transplacental lithium intoxication.

Intracranial calcifications and nephrogenic diabetes insipidus.

Cyclic adenosine monophosphate excretion in urine of patients and carriers of congenital nephrogenic diabetes insipidus.

Lack of MRI neurohypophyseal bright signal in a child with congenital nephrogenic diabetes insipidus.

The Case | Cystic renal disease, nephrogenic diabetes insipidus, and polycytemia.

Mutations in the V2 vasopressin receptor gene are associated with X-linked nephrogenic diabetes insipidus.

A novel mutation in AVPR2 causing congenital nephrogenic diabetes insipidus with complete resistance to antidiuretic hormone.

Congenital Nephrogenic Diabetes Insipidus Presented With Bilateral Hydronephrosis and Urinary Infection: A Case Report.

Mutations in the vasopressin type 2 receptor gene (AVPR2) associated with nephrogenic diabetes insipidus.

Mechanisms of prolonged lithium therapy-induced nephrogenic diabetes insipidus.

A Case of Nephrogenic Diabetes Insipidus During Transsphenoidal Pituitary Adenomectomy.

Absence of PKC-alpha attenuates lithium-induced nephrogenic diabetes insipidus.

Lithium-associated primary hyperparathyroidism complicated by nephrogenic diabetes insipidus.

Nephrogenic diabetes insipidus: clinical symptoms, pathogenesis, genetics and treatment.

Mesalazine associated nephrogenic diabetes insipidus presenting as weight loss.

Transient nephrogenic diabetes insipidus caused by fetal exposure to haloperidol.

Suggest Documents

Congenital nephrogenic diabetes insipidus.

Congenital nephrogenic diabetes insipidus with end-stage renal disease.

Congenital nephrogenic diabetes insipidus in a baby girl.

Congenital nephrogenic diabetes insipidus with a novel mutation in the aquaporin 2 gene.

Pemetrexed-Induced Nephrogenic Diabetes Insipidus.

Novel autosomal recessive gene mutations in aquaporin-2 in two Chinese congenital nephrogenic diabetes insipidus pedigrees.

Aquaporin-2: new mutations responsible for autosomal-recessive nephrogenic diabetes insipidus-update and epidemiology.

Drug-induced states of nephrogenic diabetes insipidus.

Nephrogenic diabetes insipidus in transplacental lithium intoxication.

Intracranial calcifications and nephrogenic diabetes insipidus.

Cyclic adenosine monophosphate excretion in urine of patients and carriers of congenital nephrogenic diabetes insipidus.

Lack of MRI neurohypophyseal bright signal in a child with congenital nephrogenic diabetes insipidus.

The Case | Cystic renal disease, nephrogenic diabetes insipidus, and polycytemia.

Mutations in the V2 vasopressin receptor gene are associated with X-linked nephrogenic diabetes insipidus.

A novel mutation in AVPR2 causing congenital nephrogenic diabetes insipidus with complete resistance to antidiuretic hormone.

Congenital Nephrogenic Diabetes Insipidus Presented With Bilateral Hydronephrosis and Urinary Infection: A Case Report.

Mutations in the vasopressin type 2 receptor gene (AVPR2) associated with nephrogenic diabetes insipidus.

Mechanisms of prolonged lithium therapy-induced nephrogenic diabetes insipidus.

A Case of Nephrogenic Diabetes Insipidus During Transsphenoidal Pituitary Adenomectomy.

Absence of PKC-alpha attenuates lithium-induced nephrogenic diabetes insipidus.

Lithium-associated primary hyperparathyroidism complicated by nephrogenic diabetes insipidus.

Nephrogenic diabetes insipidus: clinical symptoms, pathogenesis, genetics and treatment.

Mesalazine associated nephrogenic diabetes insipidus presenting as weight loss.

Transient nephrogenic diabetes insipidus caused by fetal exposure to haloperidol.

Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus.

Recommend Documents

Follow Us